Created at 10:22 a.m. Jan, 05, 2026
Author: ashrafkotb
Related Note: 1509142160946 2
Rationale for change

Source: First Aid 2025 page 36
The 01\_Pyrimidine\_synthesis::\*5-Fluorouracil tag is related to that card as the capecitabine is the prodrug for 5-fluorouracil that inhibits thymidylate synthase which is part of Pyrimidine synthesis

Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
Changed Tags
tag:#AK\_Step1\_v12::#FirstAid::01\_Biochem::01\_Molecular::03\_De\_novo\_pyrimidine\_and\_purine\_synthesis::01\_Pyrimidine\_synthesis::\*5-Fluorouracil
#AK_Step1_v12::#SketchyBiochem::03_Molecular_Biology::01_DNA::05_Purine_(De-Novo)_Pyrimidine_Synthesis #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::01_Methotrexate,_Leucovorin,_5-fluorouracil,_Hydroxyurea #AK_Step1_v12::#Pixorize::01_Biochemistry::02_Biochemical_Pathways::06_De_Novo_Pyrimidine_Synthesis #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#AMBOSS::hw0ciR #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::12_Antimetabolites::*Pyrimidine_Synthesis_Inhibitors::5-Fluorouracil #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::10_5-FU_Methotrexate_Leucovorin_Hydroxyurea #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::01_Antimetabolites::01_Methotrexate,_leucovorin,_5-fluorouracil,_hydroxyurea::zanki_extra #AK_Step1_v12::#Low/HighYield::4-LowerYield #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#AMBOSS::Cpaq7l #AK_Step1_v12::#Bootcamp::Genetics::01_DNA_Structure::05_Clinical_Applications_of_the_Pyrimidine_Pathway #AK_Step1_v12::#OME::PreClinical::Biochemistry #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::10_Cell_Cycle_Dependent_Drug_Targets #AK_Step1_v12::#AMBOSS::1ka25k #AK_Step1_v12::#Physeo::05_Biochem::05_Metabolism::18_Purines_&_Pyrimidines